GTG 7.69% 12.0¢ genetic technologies limited

Genetic Technologies to partner on preventative women’s health...

  1. 56 Posts.
    lightbulb Created with Sketch. 5
    https://hotcopper.com.au/data/attachments/6088/6088177-892b975a16aa8f784fc93610a9bc3a81.jpg

    Genetic Technologies to partner on preventative women’s health event in the US

    Last updated: 11:28 08 Apr 2024 AEST, First published: 11:14 08 Apr 2024 AEST

    Genetic Technologies Limited - Genetic Technologies to partner on preventative women’s health event in the US

    Genomics-based company Genetic Technologies Limited (ASX:GTG, NASDAQ:GENE, OTC:GNTLF), which specialises in health, wellness and serious disease, has struck up a partnership with Humanise Health.

    The collaboration has launched Know Your Risk, an event to be held in Pasadena, California, in May, featuring the company’s risk assessment portfolio.

    Empowering women

    The gathering will focus on empowering women with the knowledge and tools to take charge of their health, with a focus on the advancements in genomics and personalised health strategies beyond the well-known BRCA1/2 genes.

    Deploying engaging discussions led by renowned healthcare professionals, the event will:

    • allow attendees to explore the cutting-edge of genomics;
    • learn about the importance of risk assessment; and
    • discover how personalised health strategies can guide women in making informed decisions about their health.

    Event highlights include:

    Insightful clinical learnings - Delve into the latest advancements in genomics and their application in women's preventive health, featuring Angelina Jolie’s surgeon and world-renowned breast cancer expert Dr Kristi Funk.

    Empowering advocacy conversations - Global women’s health advocate Krystal Barter will facilitate a discussion with thought-leaders that aim to bring genetic testing and risk assessment to the forefront of women’s health.

    Community support - the launch of a 'Know Your Risk' campaign, which fosters a supportive community focused on empowering women to make informed decisions about their health.

    Humanise Health CEO Krystal Barter said: “I was fortunate to access genetic testing and found out I carried the BRCA1 gene mutation. Facing monumental decisions about my future health at a very young age, the crucial thing was that I had the choice.

    “This event is at the heart of Humanise Health's mission to be a valued brand partner in healthcare and to illuminate and empower each person on their unique health path.

    “Co-hosting this event with my dear friend Dr Kristi Funk, alongside global advocates, the team at GeneType, and our event partners, we're on the brink of transforming the proactive approach to women's health."

    Dr Erika Spaeth, director of clinical and scientific affairs at geneType, added: “We are thrilled to be part of the conversation around progressing the standards of women’s healthcare alongside distinguished clinicians, passionate women’s health advocates and thought leaders.

    “We are entering an era of personalised medicine, and we want to facilitate access to all women to improve preventive healthcare.”
    Hello again!

 
watchlist Created with Sketch. Add GTG (ASX) to my watchlist
(20min delay)
Last
12.0¢
Change
-0.010(7.69%)
Mkt cap ! $15.86M
Open High Low Value Volume
13.0¢ 13.0¢ 12.0¢ $4.086K 33.85K

Buyers (Bids)

No. Vol. Price($)
2 23929 12.0¢
 

Sellers (Offers)

Price($) Vol. No.
13.0¢ 27191 3
View Market Depth
Last trade - 15.47pm 10/05/2024 (20 minute delay) ?
Last
13.0¢
  Change
-0.010 ( 0.00 %)
Open High Low Volume
13.0¢ 13.0¢ 13.0¢ 3846
Last updated 12.43pm 10/05/2024 ?
GTG (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.